Adalimumab and mantle cell lymphoma Patient Reports February 10, 2012
Adalimumab Side Effects Report #4831457-X
Adalimumab side effect was reported by a Consumer or non-health professional from GREECE on Nov 10, 2005. Male patient, 70 years of age, was diagnosed with rheumatoid arthritis
and was treated with Adalimumab. After drug was administered, patient experienced the following side effects: mantle cell lymphoma, superior vena caval occlusion. Adalimumab dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, METHOTREXATE. Patient was hospitalized. Patient recovered.Adalimumab Side Effects Report #4855066-1
Adalimumab side effect was reported by a Consumer or non-health professional from GREECE on Nov 10, 2005. Male patient, 70 years of age, was diagnosed with rheumatoid arthritis
and was treated with Adalimumab. After drug was administered, patient experienced the following side effects: mantle cell lymphoma, superior vena caval occlusion. Adalimumab dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, METHOTREXATE. Patient was hospitalized. Patient recovered.
Adalimumab and mantle cell lymphoma 